US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist
  • 1.150
  • +0.030+2.68%
Trading Jul 9 11:10 ET
28.94MMarket Cap-766P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gain Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.22

+48.84%
Analyst Rating

Strong Buy

Jul 3, 2024

Gain Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 46.000K--
--2024/Q2-- / 240.000K--
--2024/Q10.000 / 90.000K--
--2023/Q40.000 / 260.000K--
--2023/Q30.000 / 93.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 46.000K--
--2024/Q2-- / 240.000K--
--2024/Q10.000 / 90.000K--
--2023/Q40.000 / 260.000K--
--2023/Q30.000 / 93.500K--

Unlock Free Earnings Estimates

Gain Therapeutics Earnings Reports

  • Gain Therapeutics | 10-Q: Quarterly report

    May 14 16:10 ET

  • Gain Therapeutics | 10-K: Annual report

    Mar 26 16:12 ET

  • Gain Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:05 ET

  • Gain Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 3, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg